{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:24:05Z","timestamp":1707524645486},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,7]]},"DOI":"10.7759\/cureus.27759","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T03:05:32Z","timestamp":1659927932000},"source":"Crossref","is-referenced-by-count":0,"title":["Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease"],"prefix":"10.7759","author":[{"given":"Naveen","family":"Dutt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saumya","family":"Shishir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishant K","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramniwas","family":"Jalandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"kuwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawan","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikarn","family":"Vishwajeet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amartya","family":"Chakraborti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Deokar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahir","family":"Asfahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"bajad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeraj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkesh","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra Kumar","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: an International Working Group report","volume":"194","author":"Collard HR","year":"2016","unstructured":"Collard HR, Ryerson CJ, Corte TJ, et al.. Acute exacerbation of idiopathic pulmonary fibrosis: an International Working Group report. Am J Respir Crit Care Med. 2016, 194:265-75. 10.1164\/rccm.201604-0801CI","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID- 19): a review","volume":"324","author":"Wiersinga WJ","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID- 19): a review. JAMA. 2020, 324:782-93. 10.1001\/jama.2020.12839","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20\u2009133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty AB","year":"2020","unstructured":"Docherty AB, Harrison EM, Green CA, et al.. Features of 20\u2009133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020, 369:m1985. 10.1136\/bmj.m1985","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.04.019","article-title":"Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic","volume":"158","author":"Wong AW","year":"2020","unstructured":"Wong AW, Fidler L, Marcoux V, et al.. Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic. Chest. 2020, 158:1069-78. 10.1016\/j.chest.2020.04.019","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2020.8980","article-title":"Pulmonary fibrosis in the aftermath of the COVID-19 era","volume":"20","author":"Vasarmidi E","year":"2020","unstructured":"Vasarmidi E, Tsitoura E, Spandidos DA, Tzanakis N, Antoniou KM. Pulmonary fibrosis in the aftermath of the COVID-19 era. Exp Ther Med. 2020, 20:2557-60. 10.3892\/etm.2020.8980","journal-title":"Exp Ther Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07033-y","article-title":"Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis","volume":"30","author":"Francone M","year":"2020","unstructured":"Francone M, Iafrate F, Masci GM, et al.. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020, 30:6808-17. 10.1007\/s00330-020-07033-y","journal-title":"Eur Radiol"},{"key":"ref8","unstructured":"Clinical management of COVID- 19. Interim guidance, 27 May 2020. (2020). https:\/\/appswhoint\/iris\/handle\/10665\/332196."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202007-2794OC","article-title":"Outcome of hospitalization for COVID-19 in patients with interstitial lung disease: an international multicenter study","volume":"202","author":"Drake TM","year":"2020","unstructured":"Drake TM, Docherty AB, Harrison EM, et al.. Outcome of hospitalization for COVID-19 in patients with interstitial lung disease: an international multicenter study. Am J Respir Crit Care Med. 2020, 202:1656-65. 10.1164\/rccm.202007-2794OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202006-2441LE","article-title":"Increased odds of death for patients with interstitial lung disease and COVID- 19: a case-control study","volume":"202","author":"Esposito AJ","year":"2020","unstructured":"Esposito AJ, Menon AA, Ghosh AJ, et al.. Increased odds of death for patients with interstitial lung disease and COVID- 19: a case-control study. Am J Respir Crit Care Med. 2020, 202:1710-3. 10.1164\/rccm.202006-2441LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v92i3.10630","article-title":"Predictors of clinical outcomes in adult COVID-19 patients admitted to a tertiary care hospital in India: an analytical cross-sectional study","volume":"92","author":"Chauhan NK","year":"2021","unstructured":"Chauhan NK, Shadrach BJ, Garg MK, et al.. Predictors of clinical outcomes in adult COVID-19 patients admitted to a tertiary care hospital in India: an analytical cross-sectional study. Acta Biomed. 2021, 92:e2021024. 10.23750\/abm.v92i3.10630","journal-title":"Acta Biomed"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2072-1439.2015.01.17","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies","volume":"7","author":"Juarez MM","year":"2015","unstructured":"Juarez MM, Chan AL, Norris AG, Morrissey BM, Albertson TE. Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies. J Thorac Dis. 2015, 7:499-519. 10.3978\/j.issn.2072-1439.2015.01.17","journal-title":"J Thorac Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03006-2020","article-title":"Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome","volume":"56","author":"Chen LY","year":"2020","unstructured":"Chen LY, Hoiland RL, Stukas S, Wellington CL, Sekhon MS. Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome. Eur Respir J. 2020, 56:10.1183\/13993003.03006-2020","journal-title":"Eur Respir J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"De Lauretis A","year":"2013","unstructured":"De Lauretis A, Sestini P, Pantelidis P, et al.. Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis. J Rheumatol. 2013, 40:435-46. 10.3899\/jrheum.120725","journal-title":"J Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.90637.2008","article-title":"Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis","volume":"299","author":"Collard HR","year":"2010","unstructured":"Collard HR, Calfee CS, Wolters PJ, et al.. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2010, 299:L3-7. 10.1152\/ajplung.90637.2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2007-0299OC","article-title":"Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice","volume":"38","author":"Saito F","year":"2008","unstructured":"Saito F, Tasaka S, Inoue K, et al.. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol. 2008, 38:566-71. 10.1165\/rcmb.2007-0299OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-882993","article-title":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms","volume":"133","author":"Jackson SP","year":"2019","unstructured":"Jackson SP, Darbousset R, Schoenwaelder SM. Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms. Blood. 2019, 133:906-18. 10.1182\/blood-2018-11-882993","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome","volume":"18","author":"Ranucci M","year":"2020","unstructured":"Ranucci M, Ballotta A, Di Dedda U, et al.. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020, 18:1747-51. 10.1111\/jth.14854","journal-title":"J Thromb Haemost"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-020-00466-z","article-title":"D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study","volume":"8","author":"Yao Y","year":"2020","unstructured":"Yao Y, Cao J, Wang Q, et al.. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. J Intensive Care. 2020, 8:49. 10.1186\/s40560-020-00466-z","journal-title":"J Intensive Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.09.018","article-title":"Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: a systematic review and meta-analysis","volume":"39","author":"Gungor B","year":"2021","unstructured":"Gungor B, Atici A, Baycan OF, et al.. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: a systematic review and meta-analysis. Am J Emerg Med. 2021, 39:173-9. 10.1016\/j.ajem.2020.09.018","journal-title":"Am J Emerg Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.05.009","article-title":"Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease","volume":"128","author":"Ishikawa G","year":"2017","unstructured":"Ishikawa G, Acquah SO, Salvatore M, Padilla ML. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease. Respir Med. 2017, 128:78-84. 10.1016\/j.rmed.2017.05.009","journal-title":"Respir Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI33288","article-title":"Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury","volume":"119","author":"Scotton CJ","year":"2009","unstructured":"Scotton CJ, Krupiczojc MA, K\u00f6nigshoff M, et al.. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest. 2009, 119:2550-63. 10.1172\/JCI33288","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.06.029","article-title":"The hypercoagulable state in COVID-19: incidence, pathophysiology, and management","volume":"194","author":"Abou-Ismail MY","year":"2020","unstructured":"Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: incidence, pathophysiology, and management. Thromb Res. 2020, 194:101-15. 10.1016\/j.thromres.2020.06.029","journal-title":"Thromb Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202007-2638LE","article-title":"Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease","volume":"203","author":"Gallay L","year":"2021","unstructured":"Gallay L, Uzunhan Y, Borie R, et al.. Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease. Am J Respir Crit Care Med. 2021, 203:245-9. 10.1164\/rccm.202007-2638LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00159709","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome","volume":"37","author":"Song JW","year":"2011","unstructured":"Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011, 37:356-63. 10.1183\/09031936.00159709","journal-title":"Eur Respir J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106226-mortality-and-its-predictors-in-covid-19-patients-with-pre-existing-interstitial-lung-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:37:11Z","timestamp":1707507431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106226-mortality-and-its-predictors-in-covid-19-patients-with-pre-existing-interstitial-lung-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,7]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.27759","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,7]]}}}